Home - Products - Metabolic Enzyme/Protease - Retinoid Receptor - BMS 195614

BMS 195614

CAS No. 253310-42-8

BMS 195614( —— )

Catalog No. M33791 CAS No. 253310-42-8

BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	397	In Stock
10MG	588	In Stock
25MG	939	In Stock
50MG	1237	In Stock
100MG	1655	In Stock
200MG	Get Quote	In Stock
500MG	3329	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BMS 195614
Note

Research use only, not for human use.
Brief Description

BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
Description

BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Metabolic Enzyme/Protease
Target

Retinoid Receptor
Recptor

Retinoid Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

253310-42-8
Formula Weight

448.51
Molecular Formula

C29H24N2O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CC1(CC=C(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)C4=CC5=CC=CC=C5N=C4)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BMS493

BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.
WYC209

WYC-209 inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs IC50: 0.19 uM). It targets the retinoic acid receptor (RAR).
MM 11253

MM 11253 is a RARγ antagonist with IC50 of 44nM.

Sign In Join Free